Yield10 Bioscience, Inc.
YTENQ
$0.015
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.03% | 34.64% | 1.12% | -6.79% | -6.91% |
| Total Depreciation and Amortization | -21.05% | -4.35% | 10.61% | 4.35% | 10.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.98% | -5.80% | -25.97% | -18.36% | -31.00% |
| Change in Net Operating Assets | 2,202.17% | 102.73% | 285.06% | 365.55% | -55.56% |
| Cash from Operations | 81.36% | 66.14% | 44.12% | 3.37% | -21.32% |
| Capital Expenditure | -- | -- | -- | 104.76% | 5.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -100.00% | -100.00% |
| Cash from Investing | -- | -- | -101.33% | -99.97% | -100.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 565.38% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -108.96% | 758.87% | -- | 13,543.48% | -- |
| Foreign Exchange rate Adjustments | 107.14% | 233.33% | -350.00% | 96.30% | 46.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -270.59% | 157.04% | -11.69% | -35.18% | -49.90% |
